BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20176723)

  • 1. Novel proapoptotic effect of hepatocyte growth factor: synergy with palmitate to cause pancreatic {beta}-cell apoptosis.
    González-Pertusa JA; Dubé J; Valle SR; Rosa TC; Takane KK; Mellado-Gil JM; Perdomo G; Vasavada RC; García-Ocaña A
    Endocrinology; 2010 Apr; 151(4):1487-98. PubMed ID: 20176723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death.
    Garcia-Ocana A; Takane KK; Reddy VT; Lopez-Talavera JC; Vasavada RC; Stewart AF
    J Biol Chem; 2003 Jan; 278(1):343-51. PubMed ID: 12403787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes.
    Mellado-Gil J; Rosa TC; Demirci C; Gonzalez-Pertusa JA; Velazquez-Garcia S; Ernst S; Valle S; Vasavada RC; Stewart AF; Alonso LC; Garcia-Ocaña A
    Diabetes; 2011 Feb; 60(2):525-36. PubMed ID: 20980460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia.
    Garcia-Ocaña A; Takane KK; Syed MA; Philbrick WM; Vasavada RC; Stewart AF
    J Biol Chem; 2000 Jan; 275(2):1226-32. PubMed ID: 10625667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
    Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
    Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of HGF/c-Met signaling in pancreatic β-cells leads to incomplete maternal β-cell adaptation and gestational diabetes mellitus.
    Demirci C; Ernst S; Alvarez-Perez JC; Rosa T; Valle S; Shridhar V; Casinelli GP; Alonso LC; Vasavada RC; García-Ocana A
    Diabetes; 2012 May; 61(5):1143-52. PubMed ID: 22427375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor ameliorates hyperglycemia and corrects β-cell mass in IRS2-deficient mice.
    Alvarez-Perez JC; Rosa TC; Casinelli GP; Valle SR; Lakshmipathi J; Rosselot C; Rausell-Palamos F; Vasavada RC; García-Ocaña A
    Mol Endocrinol; 2014 Dec; 28(12):2038-48. PubMed ID: 25361392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice.
    García-Ocaña A; Vasavada RC; Cebrian A; Reddy V; Takane KK; López-Talavera JC; Stewart AF
    Diabetes; 2001 Dec; 50(12):2752-62. PubMed ID: 11723058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose metabolism-related protein 1 (GMRP1) regulates pancreatic beta cell proliferation and apoptosis via activation of Akt signalling pathway in rats and mice.
    Wang X; Liu Y; Yang Z; Zhang Z; Zhou W; Ye Z; Zhang W; Zhang S; Yang Z; Feng X; Chen F; Hu R
    Diabetologia; 2011 Apr; 54(4):852-63. PubMed ID: 21267538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor preserves beta cell mass and mitigates hyperglycemia in streptozotocin-induced diabetic mice.
    Dai C; Li Y; Yang J; Liu Y
    J Biol Chem; 2003 Jul; 278(29):27080-7. PubMed ID: 12746445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor/c-Met signaling is required for β-cell regeneration.
    Alvarez-Perez JC; Ernst S; Demirci C; Casinelli GP; Mellado-Gil JM; Rausell-Palamos F; Vasavada RC; Garcia-Ocaña A
    Diabetes; 2014 Jan; 63(1):216-23. PubMed ID: 24089510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion.
    Gerst F; Wagner R; Kaiser G; Panse M; Heni M; Machann J; Bongers MN; Sartorius T; Sipos B; Fend F; Thiel C; Nadalin S; Königsrainer A; Stefan N; Fritsche A; Häring HU; Ullrich S; Siegel-Axel D
    Diabetologia; 2017 Nov; 60(11):2240-2251. PubMed ID: 28791439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor protects rat RINm5F cell line against free fatty acid-induced apoptosis by counteracting oxidative stress.
    Santangelo C; Matarrese P; Masella R; Di Carlo MC; Di Lillo A; Scazzocchio B; Vecci E; Malorni W; Perfetti R; Anastasi E
    J Mol Endocrinol; 2007 Feb; 38(1-2):147-58. PubMed ID: 17242177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
    Xie T; So WY; Li XY; Leung PS
    Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-zeta activation markedly enhances beta-cell proliferation: an essential role in growth factor mediated beta-cell mitogenesis.
    Vasavada RC; Wang L; Fujinaka Y; Takane KK; Rosa TC; Mellado-Gil JM; Friedman PA; Garcia-Ocaña A
    Diabetes; 2007 Nov; 56(11):2732-43. PubMed ID: 17686945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial cell line-derived neurotrophic factor increases beta-cell mass and improves glucose tolerance.
    Mwangi S; Anitha M; Mallikarjun C; Ding X; Hara M; Parsadanian A; Larsen CP; Thule P; Sitaraman SV; Anania F; Srinivasan S
    Gastroenterology; 2008 Mar; 134(3):727-37. PubMed ID: 18241861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of kinase-negative protein kinase Cdelta in pancreatic beta-cells protects mice from diet-induced glucose intolerance and beta-cell dysfunction.
    Hennige AM; Ranta F; Heinzelmann I; Düfer M; Michael D; Braumüller H; Lutz SZ; Lammers R; Drews G; Bosch F; Häring HU; Ullrich S
    Diabetes; 2010 Jan; 59(1):119-27. PubMed ID: 19826167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo activation of the PI3K-Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes.
    Hakonen E; Ustinov J; Eizirik DL; Sariola H; Miettinen PJ; Otonkoski T
    Diabetologia; 2014 May; 57(5):970-9. PubMed ID: 24493201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.
    Shimabukuro M; Zhou YT; Levi M; Unger RH
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function.
    Maedler K; Oberholzer J; Bucher P; Spinas GA; Donath MY
    Diabetes; 2003 Mar; 52(3):726-33. PubMed ID: 12606514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.